June 27, 2024
Founder-owned pacemaker company Osypka is in the market under project name Dawotec, marketed off 2024E EBITDA of 13m and revenues of EUR 40m, now in due diligence phase - acc. to sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights
.png){kind=logo}